JPMorgan Chase & Co. has disclosed a major holding increase in Bodycote plc (BOY), the UK-listed thermal processing and heat treatment services group, after its combined voting rights position crossed a notifiable threshold on 12 November 2026. The TR-1 regulatory notification, filed on 16 November 2026, reveals that JPMorgan's total position rose to 8.023078% from a previous holding of 7.933484%. The disclosure was completed in London and covers both directly held shares and cash-settled equity swaps held across multiple JPMorgan group entities. Investors in Bodycote may be watching the notification as evidence of continued institutional interest in the company.
Key Points
- Bodycote plc (BOY), ISIN GB00B3FLWH99, is the issuer subject to this major holdings notification
- JPMorgan Chase & Co. crossed a voting rights threshold in Bodycote on 12 November 2026, triggering a mandatory TR-1 disclosure
- Total combined position now stands at 8.023078%, representing 13,654,387 voting rights; previous notification stood at 7.933484%
- Investors should watch whether further threshold crossings are disclosed as JPMorgan's derivative positions approach expiry dates through 2026 and 2027
JPMorgan's Combined Voting Rights in Bodycote Rise to 8.023078% After Threshold Crossed
According to the TR-1 notification, JPMorgan Chase & Co. now holds a total of 13,654,387 voting rights in Bodycote plc, equating to 8.023078% of the company's total voting rights. This compares with the previous notified position of 7.933484%, representing an incremental increase across both share-based and financial instrument-based holdings. The position is split between 1.502160% in direct voting rights attached to shares — amounting to 2,556,496 shares held indirectly via J.P. Morgan Securities PLC — and 6.520918% held through financial instruments, primarily cash-settled equity swaps.
Cash-Settled Equity Swaps Account for the Majority of JPMorgan's Bodycote Exposure
The bulk of JPMorgan's economic exposure to Bodycote is structured through 18 separate cash-settled equity swap positions, collectively totalling 11,097,891 voting rights, or 6.520918% of Bodycote's share capital. These instruments, categorised under DTR5.3.1R.(1)(b) as financial instruments with similar economic effect, carry expiry dates ranging from 30 November 2026 through to 15 December 2027. Because these are cash-settled rather than physically settled, they do not automatically convert into direct voting rights upon expiry, a distinction that investors and analysts may consider relevant when assessing the nature of JPMorgan's overall position.
Multiple JPMorgan Entities Hold Bodycote Positions Through a Controlled Undertaking Chain
The notification identifies three JPMorgan group subsidiaries as the vehicles through which the positions are held: J.P. Morgan Securities PLC, J.P. Morgan SE, and J.P. Morgan Markets Limited, all ultimately controlled by JPMorgan Chase & Co. The full ownership chain runs through JPMorgan Chase Bank, National Association, J.P. Morgan International Finance Limited, and J.P. Morgan Capital Holdings Limited, among others. Each subsidiary in the chain is described as wholly owned at 100%. J.P. Morgan Securities PLC is specifically attributed with the 6.520918% financial instruments exposure, representing 7.729205% of the combined total allocated to that entity.




Please wait processing your request...